AYTU
Price
$2.25
Change
-$0.01 (-0.44%)
Updated
Sep 5 closing price
Capitalization
20.2M
CPHI
Price
$1.68
Change
+$0.23 (+15.97%)
Updated
Sep 5 closing price
Capitalization
5.46M
Interact to see
Advertisement

AYTU vs CPHI

Header iconAYTU vs CPHI Comparison
Open Charts AYTU vs CPHIBanner chart's image
Aytu BioPharma
Price$2.25
Change-$0.01 (-0.44%)
Volume$50.5K
Capitalization20.2M
China Pharma Holdings
Price$1.68
Change+$0.23 (+15.97%)
Volume$53.78K
Capitalization5.46M
AYTU vs CPHI Comparison Chart in %
Loading...
AYTU
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CPHI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AYTU vs. CPHI commentary
Sep 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AYTU is a Buy and CPHI is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 08, 2025
Stock price -- (AYTU: $2.25 vs. CPHI: $1.67)
Brand notoriety: AYTU and CPHI are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: AYTU: 42% vs. CPHI: 68%
Market capitalization -- AYTU: $20.2M vs. CPHI: $5.46M
AYTU [@Pharmaceuticals: Generic] is valued at $20.2M. CPHI’s [@Pharmaceuticals: Generic] market capitalization is $5.46M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $67.95B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.92B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AYTU’s FA Score shows that 0 FA rating(s) are green whileCPHI’s FA Score has 0 green FA rating(s).

  • AYTU’s FA Score: 0 green, 5 red.
  • CPHI’s FA Score: 0 green, 5 red.
According to our system of comparison, AYTU is a better buy in the long-term than CPHI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AYTU’s TA Score shows that 5 TA indicator(s) are bullish while CPHI’s TA Score has 6 bullish TA indicator(s).

  • AYTU’s TA Score: 5 bullish, 4 bearish.
  • CPHI’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, CPHI is a better buy in the short-term than AYTU.

Price Growth

AYTU (@Pharmaceuticals: Generic) experienced а -4.26% price change this week, while CPHI (@Pharmaceuticals: Generic) price change was +20.50% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +0.08%. For the same industry, the average monthly price growth was +12.00%, and the average quarterly price growth was +86.48%.

Industries' Descriptions

@Pharmaceuticals: Generic (+0.08% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AYTU($20.2M) has a higher market cap than CPHI($5.46M). AYTU YTD gains are higher at: 32.353 vs. CPHI (-27.957). AYTU has higher annual earnings (EBITDA): 10.6M vs. CPHI (-1.74M). AYTU has more cash in the bank: 18.2M vs. CPHI (625K). CPHI has less debt than AYTU: CPHI (3.43M) vs AYTU (21.4M). AYTU has higher revenues than CPHI: AYTU (81.7M) vs CPHI (4.4M).
AYTUCPHIAYTU / CPHI
Capitalization20.2M5.46M370%
EBITDA10.6M-1.74M-609%
Gain YTD32.353-27.957-116%
P/E RatioN/AN/A-
Revenue81.7M4.4M1,859%
Total Cash18.2M625K2,912%
Total Debt21.4M3.43M625%
FUNDAMENTALS RATINGS
AYTU vs CPHI: Fundamental Ratings
AYTU
CPHI
OUTLOOK RATING
1..100
82
VALUATION
overvalued / fair valued / undervalued
1..100
42
Fair valued
46
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
8698
PRICE GROWTH RATING
1..100
4660
P/E GROWTH RATING
1..100
66100
SEASONALITY SCORE
1..100
75n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

AYTU's Valuation (42) in the Other Consumer Services industry is in the same range as CPHI (46) in the Pharmaceuticals Generic industry. This means that AYTU’s stock grew similarly to CPHI’s over the last 12 months.

AYTU's Profit vs Risk Rating (100) in the Other Consumer Services industry is in the same range as CPHI (100) in the Pharmaceuticals Generic industry. This means that AYTU’s stock grew similarly to CPHI’s over the last 12 months.

AYTU's SMR Rating (86) in the Other Consumer Services industry is in the same range as CPHI (98) in the Pharmaceuticals Generic industry. This means that AYTU’s stock grew similarly to CPHI’s over the last 12 months.

AYTU's Price Growth Rating (46) in the Other Consumer Services industry is in the same range as CPHI (60) in the Pharmaceuticals Generic industry. This means that AYTU’s stock grew similarly to CPHI’s over the last 12 months.

AYTU's P/E Growth Rating (66) in the Other Consumer Services industry is somewhat better than the same rating for CPHI (100) in the Pharmaceuticals Generic industry. This means that AYTU’s stock grew somewhat faster than CPHI’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AYTUCPHI
RSI
ODDS (%)
N/A
Bullish Trend 3 days ago
79%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
89%
Bullish Trend 3 days ago
87%
Momentum
ODDS (%)
Bullish Trend 3 days ago
73%
Bullish Trend 3 days ago
86%
MACD
ODDS (%)
Bullish Trend 3 days ago
67%
Bullish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
85%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
84%
Advances
ODDS (%)
Bullish Trend 14 days ago
75%
Bullish Trend 5 days ago
82%
Declines
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 13 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
74%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bullish Trend 3 days ago
87%
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
AYTU
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CPHI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AEHL3.760.26
+7.43%
Antelope Enterprise Holdings Limited
KMTS17.000.49
+2.97%
Kestra Medical Technologies, Ltd.
RMD277.053.24
+1.18%
ResMed
MRT2.410.02
+0.84%
Marti Technologies
MWA26.780.03
+0.11%
Mueller Water Products

AYTU and

Correlation & Price change

A.I.dvisor indicates that over the last year, AYTU has been loosely correlated with IXHL. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if AYTU jumps, then IXHL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AYTU
1D Price
Change %
AYTU100%
-0.44%
IXHL - AYTU
41%
Loosely correlated
-9.48%
SBFM - AYTU
22%
Poorly correlated
-5.24%
PBH - AYTU
21%
Poorly correlated
-2.55%
CPHI - AYTU
21%
Poorly correlated
+16.32%
ETON - AYTU
20%
Poorly correlated
-1.12%
More

CPHI and

Correlation & Price change

A.I.dvisor tells us that CPHI and ASRT have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CPHI and ASRT's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CPHI
1D Price
Change %
CPHI100%
+16.32%
ASRT - CPHI
24%
Poorly correlated
-1.19%
CRON - CPHI
23%
Poorly correlated
N/A
SXTC - CPHI
22%
Poorly correlated
+16.67%
MKKGY - CPHI
21%
Poorly correlated
+1.66%
AYTU - CPHI
21%
Poorly correlated
-0.44%
More